JWCA has advised KARYOPHARM THERAPEUTCS on capital market transactions with over $375 million in transaction value
October 2018: JWCA advises Karyopharm Therapeutics on its $173 million convertible debt offering
October 2018: JWCA advises Karyopharm Therapeutics on its $173 million convertible debt offering